URS and RIRS do not worsen eGFR in CKD, with possible improvement in ureteral stones
Kidney function remains stable after surgery for kidney stones
This meta-analysis of 742 patients with pre-existing chronic kidney disease found no significant overall change in eGFR after ureteroscopy o…
New data shows that surgery to remove kidney stones does not harm kidney function and may even improve it for some patients.
Anti-GBM disease can emerge after apparent remission of ANCA-associated vasculitis in elderly patients
New antibody testing may help catch hidden kidney disease
This case report and literature review describes an 85-year-old woman with ANCA-associated vasculitis who developed subsequent anti-GBM dise…
A case study shows that a patient with one type of kidney inflammation developed a second, hidden condition.
Decellularized dental pulp extracellular matrix supports stem cell behavior and tissue architecture in preclinical models
New scaffold material shows promise for repairing dental pulp tissue
This narrative review of 101 articles examines the use of decellularized dental pulp extracellular matrix (DPECM) for pulp-dentin complex re…
A new scaffold made from dental pulp tissue helps stem cells grow and move, offering a potential path for repairing damaged teeth.
Global PD peritonitis incidence 0.31 episodes per patient-year, with wide regional variation
Global data reveals varying rates of infection in peritoneal dialysis
This meta-analysis pooled 153 unique study populations (132,000 patients, 37 countries) to estimate peritoneal dialysis-associated peritonit…
New data from 132,000 patients shows that the risk of peritonitis varies significantly depending on where a patient receives dialysis.
Traditional Chinese Medicine and modern multi-organ networks offer integrated perspectives on the kidney-bone axis
New research explores ancient and modern ways to treat bone disease
This systematic review explores the historical and modern conceptual frameworks of the kidney-bone axis in CKD-MBD. It identifies shared hol…
Researchers are looking at how ancient medicine and modern science can work together to treat bone issues caused by kidney disease.
Frailty assessments identify risk stratification and functional recovery predictors in patients undergoing hip arthroplasty
Frailty markers help predict recovery for hip replacement patients
This narrative review synthesizes frailty assessment tools for older patients undergoing hip arthroplasty. The authors conclude that while c…
New research shows that specific physical and nutritional markers can help doctors predict how well older patients will recover after hip su…
Periodontitis is associated with poorer periodontal status in patients with Parkinson's disease
Gum disease and Parkinson's disease show a linked connection
This narrative review examines the relationship between periodontitis and Parkinson's disease. While observational studies show poorer perio…
People with Parkinson's disease often have poorer gum health, but researchers say gum disease does not currently prove to cause or worsen th…
FDA Approves Zortress (everolimus) for Organ Rejection Prophylaxis in Kidney and Liver Transplant
FDA approves Zortress to help prevent organ rejection after kidney or liver transplant
The FDA has approved Zortress (everolimus) for prophylaxis of organ rejection in adult kidney transplant patients at low to moderate immunol…
The FDA has approved Zortress for adults who receive a kidney or liver transplant. It helps prevent the body from rejecting the new organ. T…
FDA Approves Kerendia (finerenone) for CKD with Type 2 Diabetes and Heart Failure
FDA Approves Kerendia for Two Heart and Kidney Conditions
The FDA approved Kerendia (finerenone), a non-steroidal mineralocorticoid receptor antagonist, to reduce the risk of sustained eGFR decline,…
The FDA approved Kerendia (finerenone) to help adults with chronic kidney disease and type 2 diabetes, and adults with a type of heart failu…
FDA Approves Jynarque (tolvaptan) for Autosomal Dominant Polycystic Kidney Disease
FDA Approves Jynarque to Slow Kidney Decline in Adults with a Genetic Kidney Disease
The FDA has approved Jynarque (tolvaptan) to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycy…
The FDA has approved Jynarque (tolvaptan) to slow kidney function decline in adults with autosomal dominant polycystic kidney disease (ADPKD…
Amino acid-based peritoneal dialysis solutions can cause chemical peritonitis mimicking bacterial peritonitis in patients
Identifying chemical peritonitis in patients on peritoneal dialysis
This case report and literature review describes a patient with peritoneal dialysis-chemical peritonitis following use of an amino acid-base…
Doctors find it hard to tell the difference between chemical and bacterial infections in patients using certain dialysis fluids.
Gut-kidney axis drives sepsis-associated AKI, review argues for microecological and neuromodulatory therapies
New Approaches Target Gut Health to Treat Sepsis Kidney Damage
This systematic review examines the gut-kidney axis as a mechanistic driver of sepsis-associated acute kidney injury and evaluates microecol…
New research explores how targeting the gut-kidney axis could help treat and prevent kidney damage in patients with sepsis.